 SAN DIEGO--BUSINESS WIRE--Arcturus Therapeutics Holdings Inc. the Company, Arcturus, Nasdaq: ARCT, a global, late-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences. Jefferies Cell and Genetic Medicine Summit Attending Thursday Friday, September 29 30, 2022 Cantor Neurology am 